Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy

Immunosuppressive therapy is mandatory for primary membranous nephropathy with persistent nephrotic proteinuria or anti-phospholipase A2 receptor antibodies, reduced kidney function, or another risk factor for progression. Rituximab has demonstrated efficacy for proteinuria remission compared with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-Rivera, Jorge, Fervenza, Fernando C., Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844164/
https://www.ncbi.nlm.nih.gov/pubmed/34932208
http://dx.doi.org/10.1007/s40265-021-01656-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844164/
https://www.ncbi.nlm.nih.gov/pubmed/34932208
http://dx.doi.org/10.1007/s40265-021-01656-1

Ejemplares similares